LAU Johnson YIU NAM
SEC-identified person · CIK 1181165 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Athenex, Inc. ATNX | Director · See Remarks | filed 2017–2023 |
| Celsus Therapeutics Plc. CLTX | Director | filed 2015–2015 |
| Chelsea Therapeutics International, Ltd. CHTP.OB | Director | filed 2006–2012 |
| Vioquest Pharmaceuticals, Inc. VQPH | Director | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.